Skip to contentSkip to Braille Studio

Library / Laws / 118th Congress / Senate Bills / S. 2362

S. 2362

To amend the Federal Food, Drug, and Cosmetic Act to provide for notification by manufacturers of critical drugs of increased demand, and for other purposes.

Print stageDateSize⠃
Introduced in Senate2023-07-186.0K⠃⠗⠋